These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 6015838

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Action mechanism and clinical success of Regelan (Clofibrate)].
    Fitzgerald JD.
    Wien Klin Wochenschr; 1967 Sep 29; 79(39):716-20. PubMed ID: 5595437
    [No Abstract] [Full Text] [Related]

  • 6. The primary preventiono of ischemic heart disease by means of Atromid-S (clofibrate).
    Oliver MF.
    Bull N Y Acad Med; 1968 Aug 29; 44(8):1021-7. PubMed ID: 4875747
    [No Abstract] [Full Text] [Related]

  • 7. [Studies on lipemia in elderly persons and the lipid lowering effect of a clofibrate derivate in 2 groups of test persons].
    Rilliet B, Monnier J.
    Praxis; 1969 Jun 24; 58(25):815-20. PubMed ID: 5819485
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of Atromid on blood lipids in patients with hyperlipemia].
    Baranova LV.
    Ter Arkh; 1968 Mar 24; 40(3):15-20. PubMed ID: 4875984
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical-experimental studies on lipid metabolism using Regelan].
    Hammerl H.
    Wien Klin Wochenschr; 1967 Sep 29; 79(39):720-2. PubMed ID: 4875575
    [No Abstract] [Full Text] [Related]

  • 10. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L, Rétsági G, Sebestyén M, Diczendy S, Erdélyi G.
    Z Gesamte Inn Med; 1966 Mar 15; 21(6):169-72. PubMed ID: 5988081
    [No Abstract] [Full Text] [Related]

  • 11. The effect of clofibrate on raised serum lipid levels.
    Smith RB, Prior IA, Cooke NJ.
    N Z Med J; 1968 Oct 15; 68(437):231-4. PubMed ID: 5247681
    [No Abstract] [Full Text] [Related]

  • 12. [Importance of the clofibrat in the treatment of lipid metabolism disorders].
    Laubinger G.
    Med Klin; 1968 Jan 26; 63(4):139-42. PubMed ID: 5670163
    [No Abstract] [Full Text] [Related]

  • 13. [The therapeutic use of CPIB in pathological increase of the lipid constituents of the blood].
    Cloarec M, Cottet J, Etienne J, Loeper J.
    Sem Ther; 1965 Nov 26; 41(9):499-500. PubMed ID: 5877602
    [No Abstract] [Full Text] [Related]

  • 14. The effect on serum tocopherol levels of drug-induced decrease in serum lipids.
    Weiss P, Bianchine JR.
    Am J Med Sci; 1969 Oct 26; 258(4):275-81. PubMed ID: 5823464
    [No Abstract] [Full Text] [Related]

  • 15. [Long-term treatment of previously therapy-resistant cases of primary hypertriglyceridemia of the adult with ethyl-p-chlorophenoxyisobutyrate].
    Braunsteiner H, Herbst M, Sandhofer F, Sailer S.
    Dtsch Med Wochenschr; 1967 Dec 15; 92(50):2302-8. PubMed ID: 6075896
    [No Abstract] [Full Text] [Related]

  • 16. [Action of a 2.2 percent solution of androsterone, in chlorphenisate, on the serum lipoproteins of low density (LDL) in patients resistant to diet therapy].
    Bertolami V, Schneiderman B, Finatti AA, Netto RF.
    Arq Bras Cardiol; 1966 Apr 15; 19(2):111-26. PubMed ID: 5943772
    [No Abstract] [Full Text] [Related]

  • 17. [The treatment of essential hyperlipidemia with clofibrate].
    Reuter W, Seifert A.
    Z Gesamte Inn Med; 1969 Jan 01; 24(1):Suppl:184-7. PubMed ID: 4918619
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical contribution to the study of the eulipemic effect of 2 ethyl esters of p-chlorophenoxyisobutyric acid].
    De Michelis S, Paparella P, Seu V.
    Clin Ter; 1969 Jul 15; 50(1):11-26. PubMed ID: 4917326
    [No Abstract] [Full Text] [Related]

  • 19. [Inborn errors of lipid metabolism. Effect of clofibrate on the level of blood lipids of patients with familial hyperlipoproteinemia (type 2, 3 and 4)].
    Sobra J, Heyrovský A, Sulc M, Horáková D.
    Cas Lek Cesk; 1969 Aug 15; 108(36):1065-9. PubMed ID: 5807234
    [No Abstract] [Full Text] [Related]

  • 20. [Clinico-experimental studies of the influence of Atherolip on lipid and carbohydrate metabolism].
    Hammerl H, Kränzl C, Pichler O, Studlar M.
    Med Welt; 1969 Aug 02; 31():1715-7. PubMed ID: 4895455
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.